Search results
Results from the WOW.Com Content Network
Most people 50 and older who use cannabis do so at least once a month, saying it helps them sleep and eases pain, a new survey found. More than 20% of older adults have used pot in the past year ...
Here’s where science currently stands on the use of marijuana for pain, sleep, anxiety, muscle spasms and other ailments — the results may surprise you. How marijuana impacts pain, sleep ...
A dried cannabis flower. The short-term effects of cannabis are caused by many chemical compounds in the cannabis plant, including 113 [clarification needed] different cannabinoids, such as tetrahydrocannabinol, and 120 terpenes, [1] which allow its drug to have various psychological and physiological effects on the human body.
The number of active chemicals in cannabis is one reason why treatment with cannabis is difficult to classify and study. [ 15 ] A 2014 review stated that the variations in ratio of CBD-to-THC in botanical and pharmaceutical preparations determines the therapeutic vs psychoactive effects (CBD attenuates THC's psychoactive effects [ 16 ] ) of ...
Average score - positive symptoms Follow up: 12 months: On average, people receiving cannabis reduction therapy scored lower than people treated with treatment as usual but there was no clear difference between groups. This finding is based on data of moderate quality. MD 0.3 lower (2.55 lower to 1.95 higher)* Moderate Quality of life
Eleven state Medicaid programs put lifetime treatment limits on how long addicts can be prescribed Suboxone, ranging between one and three years. Multiple state Medicaid programs have placed limits on how much an addict can take per dose. Such restrictions are based on the mistaken premise that addiction can be cured in a set time frame.
And the number of raids conducted during Obama's first 4 1/2 years had reached 270, in contrast to 260 during Bush's 8 years. [4] Early in President Obama's second term, in August 2013, the Justice Department issued a new Cole memo setting forth the conditions under which federal law would be enforced.
The number of research projects and scientific publications on cannabidiol and other cannabinoids in pets surged in the late 2010s; nonetheless, as of December 2020, there were no hemp-derived, cannabinoid-rich registered veterinary medicinal products in any of the major regions (see #Legal status).